---
$id: https://graph.org.ai/products/commodity/51181614
$type: Product
source: UNSPSC
code: "51181614"
title: "Carbimazole"
class: "51181600"
classTitle: "Thyroid and antithyroid drugs"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carbimazole

**UNSPSC Code**: 51181614
**Class**: [Thyroid and antithyroid drugs](Thyroid and antithyroid drugs.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antithyroid agent with the molecular formula C7H10N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8KQ660G60G, chemically known as 4-imidazoline-1-carboxylic acid, 3-methyl-2-thioxo-, ethyl ester but generally known as carbimazole, which bears US NIH Compound Identifier 31072. European Medicines Agency schedules Carbimazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06127MIG. The term CARBIMAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules carbimazole in its Anatomical Therapeutic Chemical (ATC) Classification. CARBIMAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carbimazole under HS 29332990 and SITC 51573. As of Q4 2014, CARBIMAZOLE remains the US FDA Preferred Term for this commodity. Carbimazole bears US NLM identifiers UMLS ID C0006983 and NCI Concept Code C83590. SMILES: S=C1N(CCN1C(=O)OCC)C.

